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Background: Randomized controlled trials (RCTs) are considered the most robust research design to
determine the effectiveness of interventions. RCTs comparing surgery to non-surgical alternatives are
particularly difﬁcult to perform, partly due to difﬁculties with recruitment. Low recruitment rates can
limit the internal and external validity of a trial thus understanding their causes may be important for
avoiding protracted recruitment periods. This study aimed to report patient factors that inﬂuenced
participation in a trial comparing surgery to a non-surgical treatment approach.
Methods: This study was a cross-sectional study nested within CROSSBAT (Combined Randomized and
Observational Study of Surgery For Type B Ankle Fracture Treatment). Eligible participants willing to be
randomized were randomized while those who declined randomization were offered participation in an
observational cohort. Participants from both groups (randomized and observational) were asked to
indicate their level of agreement on a 100 mm line with statements concerning reasons for acceptance or
rejection of randomization. A subset were asked to state the primary reason for agreeing to participate or
not in the trial.
Results: The nested study included 312 participants; 113 who accepted and 199 who declined
randomization. Participants unwilling to be randomized (those in the observational arm of the study)
predominantly received a non-surgical intervention. They were signiﬁcantly more worried about
receiving treatment by chance (55 mm vs. 33 mm; p < 0.0001) and had a signiﬁcantly higher preference
for one particular treatment (less equipoise) (82 mm vs 43 mm; p < 0.0001) compared to participants
willing to be randomized. Inﬂuence from clinicians and risk avoidance were primary inﬂuences of
participation. Participants’ responses regarding protocol burden, study follow-up requirements and
altruism did not signiﬁcantly differ between groups.
Conclusion: Patient non-participation in an RCT comparing surgery to no surgery is related to concern
about receiving a treatment through chance and the presence of a strong preference for a particular
treatment, particularly a non-surgical one. To avoid protracted recruitment periods, investigators can
increase the number of study sites and ensure personnel involved have equipoise and are trained to
provide a balanced view of both treatment arms.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Randomized controlled trials (RCTs) are considered the most
robust research design yet they are often arduous to perform [1].tment, Locked Bag 7103, Liv-
tal).
Inc. This is an open access article uPatient recruitment to RCTs in general is difﬁcult, often because
people have a preference for one treatment over another [2]. Sur-
gical RCTs are reported to be more problematic than drug trials
especially as the results of surgery are more permanent andmay be
associated with increased risks and costs. This issue is particularly
highlighted in surgical vs. non-surgical RCTs [3e6]. Low patient
recruitment can lead to a decrease in the scientiﬁc quality of an RCT
in a number of ways, including loss of statistical power and poorer
generalizability, and may lead to early termination [4].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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These can be related to the patient or to other factors such as
clinician or systematic factors [6]. Patient factors including
altruism, self-beneﬁt, fear of chance depicting treatment and pa-
tient preference have been identiﬁed previously as they inﬂuence a
patient’s decision to participate in an RCT [7e9]. Clinician factors
that can affect recruitment include time constraints, lack of staff
and training, concern for patients, loss of professional autonomy,
difﬁculty with the consent procedure, lack of rewards and recog-
nition, or insufﬁciently interesting research question [6]. Institu-
tional factors such as procedural, structural and infrastructural
obstacles can also affect patient recruitment. Identifying and
addressing these factors can improve patient recruitment and, thus,
improve the quality of surgical RCTs. Although these factors have
been studied in the medical RCTs, there is limited evidence on how
these factors inﬂuence patient participation in surgical vs. non-
surgical RCTs [4,6,8e10]. This study aimed to report patient fac-
tors that inﬂuenced participation in a trial comparing surgery to a
non-surgical treatment approach.
2. Methods
CROSSBAT (Combined randomized and observational study of
surgery for type B ankle fracture treatment) involved 22 hospitals
across Australia and New Zealand that were a mix of rural, regional
and metropolitan hospitals. It included a randomized group, and
participants declining randomization were invited to participate in
the observational cohort. CROSSBAT was designed to assess if sur-
gical management was superior to non-surgical management for
the treatment of type B ankle fractures with minimal talar shift.
Consecutive adult patients presenting to a recruiting hospital dur-
ing the study period with an isolated, closed OTA (Orthopedic
trauma association) type 44-B1 distal ﬁbula fracture without sig-
niﬁcant talar shift were screened for eligibility. Written, informed
consent was obtained from all participants willing to participate.
In addition to the above, inclusion criteria included patients
with no other concomitant fractures/dislocations; aged between 18
and 65 years inclusive; mobilizing unaided/independently pre-
injury and willing to be followed up for 12 months. Exclusion
criteria included participants that were medically unﬁt for anes-
thesia/surgery; skeletally immature; previous trauma or surgery to
the fractured ankle; inability to consent; pregnancy; the presence
of other injuries or co-morbidities that impede mobilization; and
non-English speaking. Eligible participants willing to be random-
ized were randomly allocated in a 1:1 ratio to either the surgical or
non-surgical intervention. Those not willing to be randomized
were invited to participate in the study as part of the observational
cohort. Members of the orthopedic team recruited participants
either in the emergency department or fracture clinics of the
participating hospitals.
At baseline, along with demographics questions, all participants
were asked to complete a survey indicating their level of agreement
with a series of statements by placing an “X” through a 100mm line
(Fig. 1). The survey questions were based on common patient
concerns regarding participation in RCTs that have been raised in
other studies, such as uncertainty of treatment; lack of participant
equipoise; protocol rationale, follow-up burden and altruism [6e8].
As the study progressed, it was evident that the majority of people
who participated in CROSSBAT (almost 2:1), opted to become
involved in the observational arm (and thus avoid the possibility of
surgery). In order to understand further what was the primary
reason for participation or not in the randomized arm, participants
in the latter stage of recruitment were probed further at six weeks
post-surgery via a telephone interview.
The primary outcome was participant level of agreement witheach statement expressed in millimetres. As this study was nested
within the CROSSBAT study, the sample size was dictated by the
CROSSBAT sample. Baseline characteristics of the two cohorts were
compared using Student’s t-test or chi-squared test. The survey
data were compared using Students’ t-test. Missing data were not
imputed. The probed responses were categorized by two in-
vestigators (RM, JN) at the conclusion of the study. The number of
participants in each category was calculated and expressed as a
percent. The percentages in each study group were compared using
chi-squared test.
The CROSSBAT protocol was approved by the relevant ethics
committees associated with each site. Approval for the nested
study was granted by the Hunter New England HREC covering the
New South Wales participants.
3. Results
A total of 312 participants were recruited in the sub-study from
August 2010 to October 2013; 113 in the randomized cohort and
199 in the observational cohort. The majority of people in the
observational cohort received a non-surgical intervention (185 vs.
14) whilst, as expected, treatment distribution was balanced in the
randomized cohort.
There were signiﬁcantly more females in the randomized
cohort. The observational cohort had a signiﬁcantly higher number
of participants with a tertiary level education. Other baseline
characteristics were similar between the two cohorts and are
shown in Table 1.
Participants in the observational cohort (i.e. those declining
randomization) were signiﬁcantly more worried about receiving
treatment by chance (mean 55 mm, 95%CI: 50.0 to 59.7 vs. 36 mm,
95%CI: 30.3 to 40.8; p < 0.0001) and had a signiﬁcantly higher level
of preference for non-surgical management, indicating they had
less equipoise (mean 82 mm, 95%CI: 78.6 to 85.0 vs. 43 mm, 95%CI:
37.2 to 48.9; p < 0.0001) when compared with the randomized
cohort, respectively. Participants in both cohorts (observational and
randomized) had similar levels of agreement with the protocol
rationale (mean 77 mm vs. 79 mm; p ¼ 0.41), follow-up burden
(mean 17 mm vs. 17 mm; p ¼ 0.96) and altruism (mean 16 mm vs.
13 mm; p ¼ 0.17). The results are shown in Table 2 and Fig. 1.
Of the subset (n ¼ 84) who were probed about their primary
reasons for participation in the randomized or observational
cohort, 25 were from the randomized arm, and 59 were from the
observational cohort. The demographics details of these 84 par-
ticipants were similar to the whole cohort as shown in Table 3.
The primary reasons for participation or not in the randomized
arms were broadly categorized into two themes - health profes-
sional inﬂuence and risks of surgery. e A higher proportion of
participants from the observational cohort preferred non-surgical
management (n ¼ 57 (97%)) and identiﬁed inﬂuence from a
health professional regarding their choice of participation (obser-
vational vs. randomized) compared to those in the randomized arm
as shown in Table 4.
A higher proportion of participants from the observational
cohort also identiﬁed risks of surgery as a factor that affected their
choice of participation (observational vs. randomized) compared to
those in the randomized arm as shown in Table 5.
4. Discussion
Recruiting for randomized controlled trials is challenging and
recruiting for surgical randomized controlled trials is associated
with particular barriers. These barriers have been broadly grouped
into patient-, surgeon- and institutional-related factors. Within the
context of an orthopedic trial, we provide some insights into
Fig. 1. Participant level of agreement with questions. X denotes the mean response on the 10 mm line. Horizontal bars indicate 95% conﬁdence interval.
Table 1
Baseline demographics.
Variable Observational cohort n ¼ 199 Randomized cohort n ¼ 113 p Value
Age, mean (SD), years 38.4 (13.5) 39.4 (13.5) 0.53
Female, no. (%) 80 (40) 62 (55) 0.012
BMI, mean (SD), kg/m2 27.1 (4.5) 28.1 (6.2) 0.14
Education, no. (%) 0.015
High school or lower 75 (39) 55 (49)
TAFE/diploma 60 (31) 40 (35)
University or above 60 (31) 18 (16)
Working, no. (%) 159 (80) 91 (81) 0.89
Insurance status, no. (%) 0.57
Public 116 (59) 73 (65)
Private 65 (33) 31 (27)
Compensation 15 (8) 9 (8)
Table 2
Participant level of agreement with questions.
Question Observational cohort Randomized cohort P value
I am worried about receiving treatment by chance 55 (2.5) 36 (2.7) <0.001
I prefer an operation 14 (1.4) 48 (2.9) <0.001
I prefer no operation 82 (1.6) 43 (3.0) <0.001
I agree with the protocol 77 (1.7) 79 (2.0) 0.41
I do not wish to be followed up 17 (1.9) 17 (2.5) 0.96
I do not think that other people with fractures similar to mine will beneﬁt from this research 16 (1.8) 13 (1.9) 0.17
Values are mean (standard deviation) in millimetres, based on a 100 mm line.
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gery to a non-surgical intervention.In our study, females were more likely to participate in the
randomized cohort. There is equivocal evidence regarding whether
Table 3
Participants that were probed vs. not probed regarding primary reason for
participation.
Variable Not probed n ¼ 228 Probed n ¼ 84 p Value
Age, mean (SD), years 38.5 (12.3) 39.3 (14.1) 0.65
Female, no. (%) 102 (45) 40 (48) 0.65
BMI, mean (SD), years 27.3 (5.3) 27.7 (4.9) 0.55
Education, no. (%) 0.13
High school or lower 103 (46) 27 (33)
TAFE/diploma 68 (30) 32 (39)
University or above 55 (23) 23 (28)
Working, no. (%) 183 (80) 67 (80) 0.92
Insurance status, no. (%) 0.39
Public 140 (62) 49 (60)
Private 67 (30) 29 (35)
Compensation 20 (8) 4 (5)
Table 4
Health professional inﬂuence on patient participation.
Health professional inﬂuence, no. (%) Observational cohort n ¼ 59 Randomized cohort n ¼ 25 p Value
No 30 (51%) 19 (76%) p ¼ 0.033
Yes 29 (49%) 6 (24%)
Table 5
Risks of surgery affecting patient participation.
Risks of surgery, no. (%) Observational cohort n ¼ 59 Randomized cohort n ¼ 25 p Value
No 19 (32%) 19 (76%) p ¼ 0.0002
Yes 40 (68%) 6 (24%)
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noted that females are less likely to participate while Jenkins et al.
found that females were more likely to participate in RCTs [11,12].
We also noted that participants with a higher level of education
were more likely to decline randomization. As for gender, there is
conﬂicting evidence about whether patients with a higher level of
education are more or less likely to participate in RCTs [2,4,13,14].
Studies have shown that patients participating in randomized
trials have altruism as a motivation for participation and are less
worried about uncertainty of treatment [6,15e22]. Our study
showed that patients who were less worried about uncertainty of
treatment were more likely to participate in the randomized
cohort. We did not observe a difference in altruism between the
groups, however, and this is possibly explained by the inclusion of
the observational arm. It is possible that people in both cohorts
(randomized and observational) had elements of altruistic behavior
guiding their choice to participate in the study. As all patients who
were eligible to participate agreed to be in either the randomized or
observational arm, we are not able to conﬁrm if people who would
do neither had less altruistic tendencies.
Most of the patients who declined randomization preferred
non-surgical management, stating risks associated with surgery as
the main reason for declining randomization and preferring non-
surgical management. Our ﬁndings were consistent with other
studies as others have shown that patients with a strong preference
for a treatment or thosewho areworried about receiving treatment
by chance are less likely to participate in an RCT [2,4,6,23]. Further,
it is known that health professionals can inﬂuence a patient’s de-
cision to participate in a trial [19,24,25]. Our study supports this as a
number of patients stated that inﬂuence from a healthcare pro-
fessional was a reason for their participation in the randomized or
observational cohorts of the study, and this was particularlypronounced for those who chose the observational arm. Our ob-
servations suggest that information provided by study personnel e
regarding the known risks and beneﬁts of the treatments under
investigation, and the extent to which true uncertainty is expressed
- has the potential to signiﬁcantly inﬂuence who and how quickly
people are recruited into a trial.
Our results suggest that participants in both cohorts did not
regard the protocol or follow-up as a concern. This may explainwhy
all patients whowere eligible to participate in CROSSBATconsented
to be part of either the randomized or observational cohort. Pre-
vious studies have shown that keeping the protocol simple, with
minimal follow-up burden can lead to improved recruitment [2,6].
In the context of our study, these factors may have helped overall
recruitment, regardless of which arm of the study a patient con-
sented to be involved in.
The study has strengths and limitations. It was nested in a large-scale, multi-centre trial both of which enhance the generalizability
of the ﬁndings. As all those screened for participation consented to
be involved in either the randomized or observational component,
our results arguably relate to why people participate or not in a RCT
compared to being involved in an observational study. This not
withstanding, as our ﬁndings echo previous studies exploring pa-
tient participation in randomized trials in the absence of an
observational arm, we contend our results usefully add to the small
body of work that currently exists in this area. In terms of limita-
tions, our study does not provide data regarding why people may or
may not participate in a surgical trial per se. Consequently, we
cannot provide recommendations regarding how to improve pa-
tient recruitment to clinical studies overall.
5. Conclusion
People who decline randomization in a surgical vs. non-surgical
trial tend to be more worried about the uncertainty of treatment
and have a stronger preference for a particular treatment. In
essence, they tend to be risk averse. Further, it appears clinicians
inﬂuence what potential participants decide. To avoid protracted
recruitment periods, investigators can increase the number of
study sites and ensure personnel involved have equipoise and are
trained to provide a balanced view of both treatment arms.
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